By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Research Digest > New Studies > Eight conditions drive 90% of multimorbidity onset in England’s 49.6 million adults
New Studies

Eight conditions drive 90% of multimorbidity onset in England’s 49.6 million adults

GMJ
Last updated: 25/05/2026 17:40
By
GMJ Research Desk
Share
8 Min Read
Data visualization showing eight medical conditions that drive multimorbidity progression in English adults
Analysis of 49.6 million English adults reveals eight conditions drive most multimorbidity cases. Socioeconomic deprivation accelerates disease progression, with concerning patterns across ethnic groups requiring targeted interventions. — Photo: RDNE Stock project / Pexels
SHARE
🎧 Listen to this article6:02 min · 860 words · GMJ Audio

Updated 25/05/2026

Contents
      • The Big Eight: Conditions driving multimorbidity in England
  • Eight conditions account for majority of first diagnoses
  • Socioeconomic deprivation strongly linked to disease progression
  • Existing conditions increase future disease risk
  • Intersectional analysis reveals complex health patterns
    • Key takeaways
  • Frequently asked questions
    • What is multimorbidity and why does it matter?
    • Why do some ethnic groups show different progression patterns?
    • How can this research improve healthcare delivery?
4 min read|801 words

A comprehensive analysis of England’s entire adult population reveals that just eight long-term conditions account for the vast majority of multimorbidity cases, with socioeconomic deprivation emerging as a powerful predictor of disease progression. The study, published in The Lancet Public Health, tracked 49.6 million adults to understand how multiple long-term conditions develop across different population groups.

49.6 million
English adults analyzed in the largest multimorbidity progression study to date

The Big Eight: Conditions driving multimorbidity in England

Eight long-term conditions identified in The Lancet Public Health study

Depression
Listed
Hypertension
Listed
Cancer
Listed
Diabetes
Listed
Asthma
Listed
Osteoarthritis
Listed
Coronary heart disease
Listed
Cerebrovascular disease
Listed

Source: The Lancet Public Health, 2025 | Georgian Medical Journal News

Submit Your Paper
GMJ_Submit_Banner

Eight conditions account for majority of first diagnoses

According to The Lancet Public Health study, eight long-term conditions (depression, hypertension, cancer, diabetes, asthma, osteoarthritis, coronary heart disease, and cerebrovascular disease) account for the majority of the first conditions people acquire in multimorbidity development. The study’s scope represents analysis of the entire adult population of England.

The research tracked how individuals transitioned from having no long-term conditions to developing multiple chronic diseases, providing insight into disease clustering patterns. The study methodology involved analyzing population-based data to identify progression patterns across demographic and socioeconomic groups.

🎙️ Related Podcast Episodes
🎧 #8 | WHO Food Safety Surveillance: Strengthening Global Systems to Detect and Prevent Foodborne Diseases · 19m
🎧 #39 | GMJ Podcast | Acne and Metabolic Dysfunction — Insulin Resistance, IGF-1, and Clinical Implications · 15m
🎧 #38 | GMJ Podcast | Acne and Metabolic Dysfunction — Insulin Resistance, IGF-1, and Clinical Implications · 21m
🎧 #24 | WHO Releases Updated Health Inequality Data Repository and Equity Toolkit · 21m

Socioeconomic deprivation strongly linked to disease progression

The Lancet Public Health study found that socioeconomic deprivation is strongly associated with multimorbidity progression. However, the research revealed an important exception: in the Black ethnic group, progression rates were high across all intersectional ethnicity and deprivation subgroups.

This finding highlights the importance of intersectional approaches in public health policy and research, according to the study authors. The pattern within Black ethnic communities suggests that traditional socioeconomic indicators may not fully capture health determinants for all population groups.

The implications extend beyond individual patient care to health policy development. Understanding these progression patterns enables healthcare systems to target interventions more effectively, potentially preventing the cascade from single conditions to complex multimorbidity cases.

Existing conditions increase future disease risk

According to The Lancet Public Health study, the presence of existing conditions is associated with higher rates of multiple long-term condition progression. This creates patterns where individuals with one condition face increased likelihood of acquiring additional diseases.

The research methodology involved sophisticated analysis to account for demographic and socioeconomic factors, ensuring the observed associations reflected genuine disease progression patterns. This approach provides evidence for prevention strategies focused on high-risk transition points. Healthcare professionals can access additional resources on managing complex cases through specialized clinical guidance platforms.

Intersectional analysis reveals complex health patterns

The study’s analysis uncovered complex relationships between ethnicity, socioeconomic status, and disease progression. According to the research published in The Lancet Public Health, while socioeconomic deprivation generally predicted multimorbidity progression, this relationship showed significant variation across ethnic groups.

The research supports approaches to multimorbidity prevention that account for population-specific factors rather than uniform strategies. This evidence base strengthens the case for public health approaches that consider the complex interplay of social, economic, and biological factors in disease development.

Eight long-term conditions account for the majority of first conditions people acquire in multimorbidity progression, with socioeconomic deprivation showing strong associations with progression rates except in the Black ethnic group where progression is high across all intersectional ethnicity and deprivation subgroups.

— The Lancet Public Health (2025)

Key takeaways

  • Eight conditions drive multimorbidity onset: depression, hypertension, cancer, diabetes, asthma, osteoarthritis, coronary heart disease, and cerebrovascular disease
  • Socioeconomic deprivation is strongly associated with disease progression, but this effect varies across ethnic groups
  • Black ethnic communities show high progression rates across all socioeconomic levels, highlighting the need for intersectional approaches
  • Existing long-term conditions are associated with higher rates of acquiring additional diseases

Frequently asked questions

What is multimorbidity and why does it matter?

Multimorbidity refers to having two or more long-term health conditions simultaneously. It affects healthcare costs, treatment complexity, and patient quality of life, making it a critical focus for healthcare planning and individual patient management.

Why do some ethnic groups show different progression patterns?

According to The Lancet Public Health study, socioeconomic factors affect disease progression differently across ethnic groups, with Black communities showing high progression rates regardless of socioeconomic level. This suggests additional systemic factors beyond traditional socioeconomic measures influence health outcomes.

How can this research improve healthcare delivery?

Understanding which conditions typically appear first and which populations face highest progression risks allows healthcare systems to target prevention efforts more effectively. This could involve enhanced screening for high-risk groups or integrated care approaches for patients with initial diagnoses.

This population-scale analysis provides evidence for healthcare systems to develop prevention strategies targeting the eight key conditions and highest-risk population groups. As healthcare systems worldwide address aging populations and rising chronic disease burdens, such targeted approaches offer a pathway toward more sustainable and equitable health outcomes.

Source: Progression of multiple long-term conditions (multimorbidity) in England: a population-based descriptive study of 49·6 million adults

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

Weekly Dual-Hormone Injection Reduces Liver Fat by 67% in Obesity TrialJul 5, 2026
Defective HIV copies explain persistent viral traces in treated patients, new study revealsJul 5, 2026
Minocycline Stroke Trial Debate Highlights Neuroprotection Research ChallengesJul 5, 2026
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood DisorderJul 4, 2026
Related reference
  • Osteoarthritis · Condition
  • Hypertension · Condition
  • Asthma · Condition
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:chronic-diseaseEnglandhealth inequalitymultimorbiditypopulation health
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Research Desk
Follow:
GMJ Research Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Medical Aid in Dying Expands to Nearly One-Third of US States by September 2024

By September 2024, nearly one-third of Americans will have legal access to…

NHS Rolls Out AI Tools to 500,000 Staff to Reduce Administrative Burden

NHS England announces AI tool deployment to over 500,000 healthcare workers, potentially…

Gene Therapy Financing Crisis: $2 Million Cures Lack Payment Infrastructure

Gene therapies costing up to $2 million per treatment face critical financing…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Scientific illustration showing genetic mechanisms of aging and youth trade-offs
New StudiesResearch Digest

Genetic Trade-off Between Youth and Longevity Discovered in Landmark Study

By
GMJ Research Desk
03/06/2026
Infographic showing brain energy consumption by age with vitamin requirements
New StudiesResearch Digest

Brain Energy Consumption Peaks at 50% in Children, Study Reveals Critical Role of B Vitamins

By
GMJ Research Desk
23/05/2026
Fluorescent microscopy image showing muscle cells with green nuclei and red membranes during fusion process
New Studies

Scientists Capture Muscle Cell Fusion in Real-Time for First Time

By
GMJ Research Desk
22/05/2026
Medical research laboratory with antiviral drug development equipment and COVID-19 treatment research
Clinical UpdatesNew StudiesPracticeResearch Digest

New Antiviral Drug Shows Promise Against COVID-19 in Clinical Research

By
GMJ Practice Desk
08/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up